Drug
Alpha 1 MP
Alpha 1 MP: highest development phase Phase 3, developed by Grifols. 5 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Alpha-1 MP NCT00295061 | Phase 3 | Alpha 1-Antitrypsin Deficiency |
| Alpha-1 MP NCT02796937 | Phase 3 | Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency |
| Alpha-1 MP NCT01983241 | Phase 3 | Pulmonary Emphysema in Alpha-1 PI Deficiency |
| Alpha-1 MP NCT02870348 | Phase 1/2 | Alpha1-Antitrypsin Deficiency |
| Alpha-1 MP NCT02870309 | Phase 1/2 | Alpha1-Antitrypsin Deficiency |
Latest
No recent events.
Follow Alpha 1 MP on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.